New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Prep: Cook: Serves:

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Last Month

Next Month

Go Back

Share this story

Comments

PD in Practice

Which physiotherapy treatment is right for you?

Physiotherapy guidelines reveal best treatments – including Tai Chi

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

The boy has raised UK £1,000 for the condition

9 stunning works of art created by people with Parkinson’s

A special gallery in London will showcase the artworks

Could virtual studies support Parkinson’s disease research?

Parkinson’s research is “hampered by inefficient recruitment and burdensome in-person assessments”, according to researchers in the US and Canada. But could virtual research have the potential to help solve some of these problems? Recruiting 203 participants from Fox Insight – an online clinical study sponsored by The Michael J Fox Foundation – the team assessed the validity of the participants’ self-reported Parkinson’s health information, and their willingness to take part in video-based research. Participants completed online questionnaires and attended two virtual visits, with a movement disorder specialist determining the likely diagnosis compared to the self-reported diagnosis. The study revealed that the participants’ self-reported diagnosis of Parkinson’s was accurate – and that 98.5% of participants would consider participating in a future study with virtual visits. The researchers concluded: “Our study demonstrates the promise of a much-needed novel model for conducting Parkinson’s research and highlights the potential of such a model for ……

Gait and tremor may be the best early predictors of Parkinson’s disease

Gait and tremor may be the most identifiable early signs of Parkinson’s disease, according to researchers from the US, France and Germany. The researchers analysed data from two large health-record databases, including an insurance company’s de-identified administrative claims. Selecting 8,382 participants with Parkinson’s disease, the scientists evaluated individual occurrences of reported symptoms over time – and how these corresponded to their Parkinson’s diagnosis. The analysis revealed a “pre-diagnostic window” in which symptoms were reported but no diagnosis of Parkinson’s disease was made. The most dominant symptoms in this pre-diagnostic window were abnormal gait and tremor, highlighting “the existence of a population of [Parkinson’s] patients whose diagnoses can be accelerated”. The researchers concluded: “Accurate, prospective identification of high-risk individuals would allow for earlier diagnosis, intervention and more effective large-scale evaluation of potential therapeutics.”

Air pollution may be linked to greater risk of Parkinson’s disease

A study from researchers in South Korea suggests that exposure to nitrogen dioxide (NO2), a gas associated with car and power plant emissions, could increase the risk of Parkinson’s disease. Using Korean National Health Insurance Service data, the researchers identified 78,830 participants above age 40 who had lived in Seoul during a certain time frame – and had not been diagnosed with Parkinson’s disease before 2006. During the study period of January 2007 to December 2015, 338 of the participants were diagnosed with the condition. The team then used participant addresses to determine the degree of air pollution exposure. The analysis revealed that those with the highest NO2 exposure had a “statistically significant” greater risk of being diagnosed with Parkinson’s disease. “These findings suggest that regulation of air pollutants might reduce the incidence of Parkinson’s disease,” wrote the researchers, “advocating for the need to implement a targeted public health policy.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

PD in Practice

Which physiotherapy treatment is right for you?

Interviews

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

Europe

9 stunning works of art created by people with Parkinson’s

Could virtual studies support Parkinson’s disease research?

Gait and tremor may be the best early predictors of Parkinson’s disease

Air pollution may be linked to greater risk of Parkinson’s disease

{title}

Subscribe

New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

PD in Practice

Which physiotherapy treatment is right for you?

Interviews

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

Europe

9 stunning works of art created by people with Parkinson’s

Could virtual studies support Parkinson’s disease research?

Gait and tremor may be the best early predictors of Parkinson’s disease

Air pollution may be linked to greater risk of Parkinson’s disease

{title}

Subscribe

Sign in